FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Composition",
  "id": "composition-diflucan",
  "meta": {
    "versionId": "1",
    "lastUpdated": "2026-06-17T10:00:00Z",
    "profile": [
      "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/composition-epi-type1"
    ]
  },
  "language": "en",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "identifier": [
    {
      "system": "http://example.org/identifier",
      "value": "composition-diflucan"
    }
  ],
  "version": "1.0",
  "status": "final",
  "type": {
    "coding": [
      {
        "system": "https://spor.ema.europa.eu/rmswi",
        "code": "100000155532",
        "display": "Summary of Product Characteristics"
      }
    ]
  },
  "subject": [
    {
      "reference": "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-diflucan"
    }
  ],
  "date": "2026-06-17",
  "author": [
    {
      "reference": "Organization/org-diflucan"
    }
  ],
  "title": "Diflucan 150 mg capsule - Summary of Product Characteristics",
  "section": [
    {
      "id": "diflucan-root",
      "title": "SUMMARY OF PRODUCT CHARACTERISTICS",
      "code": {
        "coding": [
          {
            "system": "https://spor.ema.europa.eu/rmswi",
            "code": "200000029791",
            "display": "SUMMARY OF PRODUCT CHARACTERISTICS"
          }
        ]
      },
      "text": {
        "status": "generated",
        "div": "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\">Summary of Product Characteristics for Diflucan</div>"
      },
      "section": [
        {
          "id": "diflucan-4-1",
          "title": "4.1 Therapeutic indications",
          "code": {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi",
                "code": "200000029799",
                "display": "4.1 Therapeutic indications"
              }
            ]
          },
          "text": {
            "status": "generated",
            "div": "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Treatment of mucosal and invasive candidiasis.</p></div>"
          },
          "entry": [
            {
              "reference": "ClinicalUseDefinition/cud-diflucan-mucosal"
            },
            {
              "reference": "ClinicalUseDefinition/cud-diflucan-invasive"
            }
          ]
        },
        {
          "id": "diflucan-4-2",
          "title": "4.2 Posology and method of administration",
          "code": {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi",
                "code": "200000029800",
                "display": "4.2 Posology and method of administration"
              }
            ]
          },
          "text": {
            "status": "generated",
            "div": "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Dose depends on the indication and the patient population (see structured dosing). Renal impairment requires dose adjustment for multiple-dose therapy.</p></div>"
          },
          "entry": [
            {
              "reference": "MedicationKnowledge/mk-diflucan"
            },
            {
              "reference": "ClinicalUseDefinition/cud-diflucan-renal"
            }
          ]
        }
      ]
    }
  ]
}